7 result(s) displayed (1 - 7 of 7):

Merck feeds pipeline with deals big and small (from Corporate Dealmaker)

Merck & Co. (NYSE:MRK) is hoping to strengthen its pipeline and broaden its portfolio with its planned $41.1 billion acquisition of Schering-Plough Corp. (NYSE:SGP). But the megadeal hasn't distracted it from pursuing the kind of smaller licensing deals that have become an increasingly important tool for cost-conscious pharma giants.   Merck...

Posted on April 9, 2009 8:03 AM

GlaxoSmithKline says small companies want to be bought (from Corporate Dealmaker)

GlaxoSmithKline plc CEO Andrew Witty said small drug companies squeezed by the credit crunch are turning to GSK to discuss being acquired,  The Wall Street Journal reported. So GSK may step up its acquisition activity in the coming months. The pharma giant is already active. The Deal's Cheryl Meyer notes...

Posted on October 23, 2008 1:51 PM

From Shearman & Sterling to the middle of the Bristol-Myers makeover (from Corporate Dealmaker)

Charles Simmons left Shearman & Sterling LLP in 2000, joining Bristol-Myers Squibb Co. as an M&A lawyer to help get big deals done. And so he did: Within his first 12 months on the job, the restructuring healthcare giant sold its Clairol hair and beauty business to Procter & Gamble...

Posted on September 16, 2008 1:43 PM

Outsourcing's fickle factor (from Corporate Dealmaker)

Hewlett-Packard Co.'s $13.9 billion deal for Electronic Data Systems Corp. catapulted business processing outsourcing back into the spotlight. A big driver behind the deal is HP's desire to take on industry leader IBM Corp. Competition for BPO contracts is stiff, with dozens of providers in the U.S. and abroad going...

Posted on June 6, 2008 8:10 AM

Healthcare Symposium 2008: Corporate Dealmaker panelists (from Corporate Dealmaker)

At The Deal's Healthcare Dealmaking Symposium on March 19, CD editor Ken Klee will moderate a panel including corporate development pros working in the field. Attendees will hear insights from Christine Arakelian, vice president of...

Posted on March 13, 2008 9:46 AM

Bristol-Myers taps dealmaker as new CFO (from Corporate Dealmaker)

On March 31, Andrew Bonfield, executive vice president and chief financial officer of Bristol-Myers Squibb Co., will relinquish his role to Jean-Marc Huet. Huet (pictured) comes to BMS from the world of baby food. He was the engineer behind Amsterdam-based Royal Numico NV's acquisition strategy and their eventual $16.8 billion...

Posted on March 5, 2008 12:08 PM

Fourth-quarter-boosting acquisitions (from Corporate Dealmaker)

One quarter doesn't determine the success of a deal, but quarterly earnings reports do offer a chance to check up on how various acquisitions have fared since they closed. The headliner for this quarter would have to be last year's pharmacy chain merger of equals between CVS Corp. and Caremark...

Posted on January 31, 2008 2:23 PM